Synthesis of DNA–1° Antibody Conjugates.

NK Nataly Kravchenko-Balasha
YS Young Shik Shin
AS Alex Sutherland
RL R. D. Levine
JH James R. Heath
request Request a Protocol
ask Ask a question
Favorite

As-received antibodies (Table S2) were desalted, buffer exchanged to pH 7.4, 1× PBS and concentrated to 0.5 mg/mL using Zeba protein desalting spin columns (Pierce). Succinimidyl 4-hydrazinonicotinate acetone hydrazine (SANH) (Solulink) in N,N-dimethylformamide (DMF) was added to the antibodies at variable molar excess of (300:1) of SANH to antibody. Separately, succinimidyl 4-formylbenzoate (SFB) (Solulink) in DMF was added at 16-fold molar excess to 5′-aminated 30-mer oligomers in 1× PBS. After incubation for 4 h at room temperature, excessive SANH and SFB were removed by buffer exchange of both samples to pH 6.0 citrate buffer using protein desalting spin columns. A 30-fold excess of derivative DNA was then combined with the antibody and allowed to react for 2 h at room temperature followed by overnight incubation at 4 °C. Noncoupled DNAs were removed by FPLC with Pharmacia Superdex 200 gel filtration column (GE) at 0.5 mL/min isocratic flow of 1× PBS. The conjugates were then concentrated to 0.5 mg/mL by Amicon Ultra-4 Centrifugal Filter Unit with Ultracel-10 membrane (Millipore 10 kDa) and stored at 4 °C. The conjugation yield was determined by protein BCA assay with Nanodrop 2000C (Thermo Scientific).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A